RT Journal Article
SR Electronic
T1 COVID-19 in healthcare workers in three hospitals in the South of the Netherlands, March 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.26.20079418
DO 10.1101/2020.04.26.20079418
A1 Sikkema, Reina S.
A1 Pas, Suzan
A1 Nieuwenhuijse, David F.
A1 O’Toole, Áine
A1 Verweij, Jaco
A1 van der Linden, Anne
A1 Chestakova, Irina
A1 Schapendonk, Claudia
A1 Pronk, Mark
A1 Lexmond, Pascal
A1 Bestebroer, Theo
A1 Overmars, Ronald J.
A1 van Nieuwkoop, Stefan
A1 van den Bijllaardt, Wouter
A1 Bentvelsen, Robbert G.
A1 van Rijen, Miranda M.L.
A1 Buiting, Anton G.M.
A1 van Oudheusden, Anne J.G.
A1 Diederen, Bram M.
A1 Bergmans, Anneke M.C.
A1 van der Eijk, Annemiek
A1 Molenkamp, Richard
A1 Rambaut, Andrew
A1 Timen, Aura
A1 Kluytmans, Jan A.J.W.
A1 Oude Munnink, Bas B.
A1 Kluytmans van den Bergh, Marjolein F.Q.
A1 Koopmans, Marion P.G.
YR 2020
UL http://medrxiv.org/content/early/2020/05/01/2020.04.26.20079418.abstract
AB Ten days after the first reported case of SARS-CoV-2 infection in the Netherlands, 3.9% of healthcare workers (HCWs) in nine hospitals located in the South of the Netherlands tested positive for SARS-CoV-2 RNA. The extent of nosocomial transmission that contributed to the HCW infections was unknown.We combined epidemiological data, collected by means of structured interviews of HCWs, with whole genome sequencing (WGS) of SARS-CoV-2 in clinical samples from HCWs and patients in three of nine hospitals that participated in the HCW screening, to perform an in-depth analysis of sources and modes of transmission of SARS -CoV-2 in HCWs and patients.A total of 1,796 out of 12,022 HCWs (15%) of the three participating hospitals were screened, based on clinical symptoms, of whom 96 (5%) tested positive for SARS-CoV-2. We obtained complete genome sequences of 50 HCWs and 18 patients. Most sequences grouped in 3 clusters, with 2 clusters displaying local circulation within the region. The observed patterns are most consistent with multiple introductions into the hospitals through community acquired infections, and local amplification in the community.Although direct transmission in the hospitals cannot be ruled out, the data does not support widespread nosocomial transmission as source of infection in patients or healthcare workers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study has been partly funded by H2020 projects RECoVer (no. 101003589), VEO (No. 874735) and NIAID/NIH contract HHSN272201400008CAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available upon request